| Bid | 33.5 |
| Market Cap | 953.94M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.59 |
| PE Ratio (ttm) | -12.81 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 35 |
| Volume | 1,928,130 |
| Avg. Volume (20D) | 481,375 |
| Open | 34.86 |
| Previous Close | 33.71 |
| Day's Range | 31.14 - 36.42 |
| 52-Week Range | 30.20 - 60.12 |
| Beta | undefined |
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as dis...
Analyst Forecast
According to 6 analyst ratings, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $62.5, which is an increase of 88.45% from the latest price.
Next Earnings Release
Analysts project revenue of $44.40M, reflecting a 40.68% YoY growth and earnings per share of -0.65, making a -17.72% decrease YoY.
2 months ago · seekingalpha.com
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call TranscriptEstablishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Co...
2 months ago · businesswire.com
Establishment Labs Announces $50 Million Registered Direct OfferingNEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...
